MarieBleakleyMD

Pediatric Hematology & Oncology • Seattle, WA

Assistant Professor, Pediatrics, University of Washington School of Medicine

Join to view full profile

Dr. Bleakley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bleakley's full profile

Already have an account?

Office
4800 Sand Point Way NE
Seattle, WA 98105
Phone+1 206-288-1000

Fax+1 206-606-1025

Education & Training

University of WashingtonFellowship, Pediatric Hematology/Oncology, 2002 - 2005
The Flinders University of South Australia School of MedicineClass of 1994

Certifications & Licensure

WA State Medical License 2004 - 2026

Clinical Trials

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD Start of enrollment: 2009 Dec 17
Terminated
Phase 2
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children Start of enrollment: 2014 Apr 10
Completed
Phase 2
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Start of enrollment: 2015 Feb 03
Active, not recruiting
Phase 2
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant Start of enrollment: 2018 Feb 23
Suspended
Phase 1
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Start of enrollment: 2019 Aug 29
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) Start of enrollment: 2019 Nov 19
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignancies.
Melinda A Biernacki, Marie Bleakley
Expert Review of Hematology. 2024-12-16
6 citations
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Elizabeth F Krakow, Michelle Brault, Corinne Summers, Tanya M Cunningham, Melinda A Biernacki
Blood. 2024-09-05
Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies.
Emily R Cox, Corinne Summers, Filippo Milano, Ann Dahlberg, Marie Bleakley
Annals of Hematology. 2024-09-01

Lectures

Blood Drops: Leading a Translational Research Team
60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

Peach Bowl Inc. Funds 5 New Research Projects at Children’s Healthcare of AtlantaNovember 2nd, 2022
A Twist on Stem Cell Transplants Could Help Blood Cancer PatientsFebruary 10th, 2022
Fundamental Proteins That Guide Embryo Development Are Co-Opted by CancerFebruary 19th, 2021
Join now to see all